Table 7 Factors associated with hospital-acquired infections
Organism | Risk factor* | P-value | OR | 95% CI | |
|---|---|---|---|---|---|
Lower | Upper | ||||
Enterococcus spp. | Gender | 0.0757 | – | – | – |
Ampicillin resistance | 0.0757 | 3.13 | 0.86 | 11.37 | |
Streptomycin resistance | 0.01431 | – | – | – | |
S. aureus | MDR | 0.014 | – | – | – |
Clindamycin/Erythromycin resistance | 0.014 | – | – | – | |
Cefoxitin/Oxacillin resistance |  < 0.001 | 7.62 | 1.36 | 42.71 | |
Linezolid/Rifampicin/Vancomycin resistance |  < 0.001 | – | – | – | |
AMR genes | 0.02 | – | – | – | |
K. pneumoniae | Gender | 0.06136 | – | – | – |
Race | 0.1082 | – | – | – | |
Ciprofloxacin resistance | 0.1 | – | – | – | |
Imipenem resistance | 0.1285 | – | – | – | |
Colistin resistance |  < 0.001 | – | – | – | |
A. baumannii | Imipenem/Piperacillin-tazobactam/Colistin resistance |  < 0.001 | – | – | – |
AMR genes | 0.1185 | – | – | – | |
P. aeruginosa | Ceftazidime resistance | 0.01721 | 5.04 | 1.24 | 20.43 |
Cefotaxime resistance | 0.05676 | – | – | – | |
Imipenem resistance | 0.1083 | – | – | – | |
Meropenem resistance | 0.0468 | – | – | – | |
AMR Genes | 0.113 | – | – | – | |
Enterobacter spp. | Amikacin resistance | 0.1025 | – | – | – |
Ceftazidime resistance | 0.0611 | – | – | – | |
Ceftriaxone/Cefotaxime resistance | 0.0379 | 7.50 | 0.87 | 64.36 | |
E. coli | Gender | 0.1056 | – | – | – |
MDR | 0.09166 | – | – | – | |
Piperacillin-tazobactam resistance | 0.09584 | – | – | – | |